Loading clinical trials...
Loading clinical trials...
The risk of adrenal insufficiency in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency is not well documented. Indication of cortisol replacement therapy in si...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT06900153 · CAH - 21-Hydroxylase Deficiency
NCT03687242 · Congenital Adrenal Hyperplasia, CAH - Congenital Adrenal Hyperplasia, and more
NCT00519818 · Congenital Adrenal Hyperplasia, 21-Hydroxylase Deficiency, and more
NCT00529841 · Adrenal Hyperplasia, Congenital
NCT01488721 · Adrenal Hyperplasia, Congenital, Congenital Hypothyroidism, and more
Assistance Publique - Hôpitaux de Paris, Bicêtre Hospital
Le Kremlin-Bicêtre
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions